(Q40550087)

English

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial (English)

1 reference

Europe PubMed Central

21 September 2017

Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial (English)

1 reference

10.1016/S0302-2838(03)00357-9

https://api.crossref.org/works/10.1016/S0302-2838(03)00357-9

11 March 2024

phase III clinical trial

0 references

bladder neoplasm

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0302-2838(03)00357-9

https://api.crossref.org/works/10.1016/S0302-2838(03)00357-9

11 March 2024

author name string

Wim Oosterlinck

3

1 reference

Europe PubMed Central

21 September 2017

Wolfgang Hoeltl

4

1 reference

Europe PubMed Central

21 September 2017

EORTC Genito-Urinary Tract Cancer Group

6

1 reference

Europe PubMed Central

21 September 2017

Adrian P. M. van der Meijden

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499676

11 March 2024

Richard J. Sylvester

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499676

11 March 2024

Aldo V. Bono

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14499676

11 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

21 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0302283803003579?httpAccept=text/xml

1 reference

10.1016/S0302-2838(03)00357-9

https://api.crossref.org/works/10.1016/S0302-2838(03)00357-9

11 March 2024

https://api.elsevier.com/content/article/PII:S0302283803003579?httpAccept=text/plain

1 reference

10.1016/S0302-2838(03)00357-9

https://api.crossref.org/works/10.1016/S0302-2838(03)00357-9

11 March 2024

European Urology

1 reference

Europe PubMed Central

21 September 2017

44

1 reference

Europe PubMed Central

21 September 2017

429-434

1 reference

Europe PubMed Central

21 September 2017

4

1 reference

Europe PubMed Central

21 September 2017

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerability of bacille Calmette-Guérin maintenance therapy for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900357-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0302-2838(03)00357-9

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40550087&oldid=2099727240"